ELI LILLY AND COMPANY Income Taxes Paid
ELI LILLY AND COMPANY (LLY) reported Income Taxes Paid of $10.81 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-02-12
- ELI LILLY AND COMPANY income taxes paid, net for fiscal 2025 was $10.81B, a 64.80% increase from fiscal 2024.
- ELI LILLY AND COMPANY income taxes paid, net for fiscal 2024 was $6.56B, a 18.04% increase from fiscal 2023.
- ELI LILLY AND COMPANY income taxes paid, net for fiscal 2023 was $5.56B.
- ELI LILLY AND COMPANY income taxes paid, net for fiscal 2010 was $861.00M, a 1622.00% increase from fiscal 2009.
| Period end | Income Taxes Paid, Net 12 month | Income Taxes Paid, Net 12 month as first filed |
|---|---|---|
| 2025-12-31 | $10.81B 10-K · filed 2026-02-12 | |
| 2024-12-31 | $6.56B 10-K · filed 2026-02-12 | |
| 2023-12-31 | $5.56B 10-K · filed 2026-02-12 | |
| 2010-12-31 | $861.00M 10-K · filed 2011-02-22 | |
| 2009-12-31 | $50.00M 10-K · filed 2012-02-24 | $1.14B 10-K · filed 2011-02-22 |
| 2008-12-31 | -$52.00M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |